BGR 34 by AIMIL is a researched product approved by CSIR. It is known to be highly effective in treating Type 2 Diabetes. It acts as a DPP-4 inhibitor, regulates insulin secretion, converts proinsulin to insulin, and supplements and nourishes vital organs.
INDICATIONS: Diabetes and complications
DOSE: 2 tablets twice a day, half an hour before meals or as directed by the physician